MedCity News dissects E&Y’s “Biotechnology Report 2016”

MedCity NewsMedCity News dissects Ernst & Young’s “Biotechnology Report 2016” and concludes that it is still a strong sector, just not as strong as in recent years. Read the analysis here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.